By Davit Kirakosyan Novavax, Inc. (NASDAQ:NVAX) announced late Tuesday that the U.S. Food and Drug Administration (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC)...
By Peter Nurse Investing.com -- Stocks in focus in premarket trade on Monday, May 23rd. Please refresh for updates. VMware (NYSE:VMW) stock soared 23% after the Wall Street Journal reported...
By Liz Moyer Investing.com -- Pfizer Inc (NYSE:PFE) shares rose after the Food and Drug Administration approved its Covid-19 booster shot for children aged 5 to 11. Pfizer stock rose...
By Yasin Ebrahim Investing.com -- The Dow slumped Monday, as tech and energy led a wave of selling on Wall Street in the wake of growing concerns about an inflation-led slowdown in global...
By Yasin Ebrahim Investing.com -- The S&P 500 slumped Monday, paced by a selloff in energy and tech as investors continued to abandon stocks amid concerns about an inflation-led slowdown in...
Shares of BioNTech (NASDAQ:BNTX) are up around 1.5% in pre-open Monday after the biotech company reported better-than-expected Q1 EPS and revenue. The German biotechnology company...
By Peter Nurse Investing.com -- Stocks in focus in premarket trade on Monday, May 9th. Please refresh for updates. Rivian Automotive (NASDAQ:RIVN) stock fell 17% after CNBC reported...
By Peter Nurse Investing.com -- U.S. stocks are seen opening lower Monday, continuing the recent selloff ahead of the release of the latest consumer inflation data which could see the...
BioNTech SE (NASDAQ:BNTX) reported Q1 EPS of EUR14.24. Revenue for the quarter came in at EUR6.4 billion.The company reiterated COVID-19 2022 vaccine revenue guidance of €13 billion to €17...
By Oliver Gray Investing.com - Dow futures declined on Sunday evening following a volatile week of trading after Federal Reserve policymakers raised interest rates by a half percentage...
By Sam Boughedda Investing.com -- U.S. indices are moving lower Wednesday with the Nasdaq down around 0.7% at midday. Here are the midday movers on Wednesday, March 30th. BioNTech SE...
By Geoffrey Smith Investing.com -- U.S. stock markets opened lower on Wednesday as the peace euphoria of Tuesday faded against a backdrop of continued Russian offensives in part of Ukraine....
Pre-Open Stock Movers:Adagio (ADGI) 50% HIGHER; ADG20 Met Primary Endpoints Across Pre- and Post-exposure Prophylaxis and Treatment for COVID-19Chewy (NYSE:CHWY) 14% LOWER; reported Q4...
By Peter Nurse Investing.com -- Stocks in focus in premarket trade on Wednesday, March 30th. Please refresh for updates. Micron Technology (NASDAQ:MU) stock rose 3.4% after the company gave...
By Dhirendra Tripathi Investing.com – BioNTech (NASDAQ:BNTX) stock gained 8% in premarket trading Wednesday after the company beat fourth-quarter estimates and promised to channel its...
BioNTech SE (NASDAQ:BNTX) reported Q4 EPS of EUR12.18. Revenue for the quarter came in at EUR5.53 billion. Estimated BioNTech COVID-19 vaccine revenues for the full 2022 financial year EUR13...
By Oliver Gray Investing.com - U.S. stock futures were trading slightly lower in early APAC deals on Monday, as investors look ahead to a series of key economic reports later in the week,...
By Dhirendra Tripathi Investing.com – Shares of vaccine makers traded higher Wednesday after Pfizer-BioNTech (NYSE:PFE) (NASDAQ:BNTX) sought U.S. FDA’s emergency use authorization for a...
By Geoffrey Smith Investing.com -- U.S. stock markets opened mixed on Monday as hopes for a diplomatic settlement to the war in Ukraine evaporated amid signs that Russia is pursuing its...
(Bloomberg) -- Moderna (NASDAQ:MRNA) Inc.’s shares have dropped 50% this year as investors pulled back from Covid-19 healthcare stocks and staged a broader rotation out of growth...
By Dhirendra Tripathi Investing.com – Pfizer stock (NYSE:PFE) fell 3.5% in premarket trading Tuesday after the company’s fourth-quarter revenue fell short of expectations,...
By Carjuan Cruz Investing.com - Shares of Pfizer (NYSE:PFE) soared 3.6% today as the U.S. Food and Drug Administration (FDA) announced it cleared Pfizer's antiviral pill, Paxlovid, to...
Investing.com - The new covid-19 interest variant, called Omicron, sent the markets into a tailspin last week, and is likely to remain the main focus for investors this week. As there was a...
By Sam Boughedda Investing.com — Covid-19 related vaccine stocks have made gains Friday after concerns were raised about a new coronavirus variant in South Africa that is said to have...
By Geoffrey Smith Investing.com -- U.S. stocks tumbled at the opening of a holiday-shortened session on Friday, as concerns about a new and potentially vaccine-resistant variant of Covid-19...
By Peter Nurse Investing.com -- Stocks in focus in premarket trade on Friday, November 26th. Please refresh for updates. American Airlines (NASDAQ:AAL) stock fell over 7%, with Delta Air...
(Bloomberg) -- A year ago, Pfizer Inc.'s (NYSE:PFE) shockingly good Covid-19 vaccine efficacy data triggered bets that cheap stocks would outperform shares of fast-growing companies in...
By Noreen Burke Investing.com -- Data on inflation will be the highlight of the U.S. economic calendar in the week ahead as investors continue to digest the Federal Reserve’s decision to...
By Dhirendra Tripathi Investing.com – Novavax stock (NASDAQ:NVAX) was looking to extend its previous session’s gains Tuesday after its Covid-19 vaccine secured its first...
By Dhirendra Tripathi Investing.com – Moderna stock (NASDAQ:MRNA) rose 3.2% on Monday as the company said it would be approaching the Food and Drug Administration and other...
By Dhirendra Tripathi Investing.com – Shares of vaccine-makers traded higher Tuesday on a report in The New York Times that the Food and Drug Administration plans to allow people to...
By Dhirendra Tripathi Investing.com – Johnson & Johnson stock (NYSE:JNJ) rose by 0.5% in Wednesday’s trading as the Food and Drug Administration said the company’s...
By Dhirendra Tripathi Investing.com – Johnson & Johnson stock (NYSE:JNJ) rose 0.7% Tuesday as the company applied to the U.S. Food and Drug Administration for emergency use approval to...
By Dhirendra Tripathi Investing.com – Novavax stock (NASDAQ:NVAX) climbed 9% Thursday after the company applied with the World Health Organization for emergency approval to its...
By Dhirendra Tripathi Investing.com – Pfizer stock (NYSE:PFE) rose 0.4% on Monday after it said its Covid-19 vaccine was found to be safe for children aged 5 to 11 years. Its German...
By Dhirendra Tripathi Investing.com – Shares of vaccine makers rose Thursday on an NBC News report that the Biden administration plans to make it mandatory for federal workers to get...
(Bloomberg) -- The huge rally for Covid-19 vaccine makers has stalled as Wall Street waits for the U.S Centers for Disease Control and Prevention to weigh in on whether Americans should get...
(Bloomberg) -- Pfizer Inc. (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) announced a deal with a Brazilian manufacturer to produce 100 million doses of their Covid-19 vaccine annually for...
By Peter Nurse Investing.com -- Crude oil prices rose Tuesday, extending recent gains after Mexico suffered a substantial production outage, limiting the potential supply to the global...
By Oliver Gray Investing.com - U.S. Stock futures moved slightly higher in early APAC trade on Tuesday, following a positive close in the previous session that saw the major benchmarks...
By Dhirendra Tripathi Investing.com – Moderna stock (NASDAQ:MRNA) rose 5% Tuesday as the U.K. regulator approved its Covid-19 shot for being given to children aged 12 to 17. The...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
